With a strong focus on medical advancements, afreeze aims to combat atrial fibrillation, the most common cardiac rhythm disease affecting over 14 million people in the industrialized world today. Their innovative coolloop® catheter is a powerful and precise device specifically designed for combating atrial fibrillation, delivering exceptional results for patients. By targeting this significant market, afreeze offers a groundbreaking solution for efficient therapy.

As a brand, afreeze prioritizes patient care and satisfaction, ensuring that individuals suffering from atrial fibrillation can find relief and hope through their cutting-edge products. For inquiries and further information, don't hesitate to reach out to afreeze GmbH located at Eduard Bodem Gasse 8/EG, 6020 Innsbruck, Austria. Contact them today and discover how afreeze is transforming the medical field one breakthrough at a time